Latest Insider Transactions at Recursion Pharmaceuticals, Inc. (RXRX)
This section provides a real-time view of insider transactions for Recursion Pharmaceuticals, Inc. (RXRX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of RECURSION PHARMACEUTICALS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of RECURSION PHARMACEUTICALS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 10
2024
|
Michael Secora Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
39,375
+2.87%
|
$78,750
$2.22 P/Share
|
|
Jul 09
2024
|
Blake Borgeson Director |
SELL
Open market or private sale
|
Direct |
11,447
-0.16%
|
$80,129
$7.32 P/Share
|
|
Jul 09
2024
|
Michael Secora Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
15,000
-1.15%
|
$105,000
$7.32 P/Share
|
|
Jul 09
2024
|
Michael Secora Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
39,375
+2.92%
|
$78,750
$2.22 P/Share
|
|
Jul 01
2024
|
Blake Borgeson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,441
+0.02%
|
-
|
|
Jul 01
2024
|
Terry Ann Burrell Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,843
+2.52%
|
-
|
|
Jul 01
2024
|
Zavain Dar Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,843
+1.74%
|
-
|
|
Jul 01
2024
|
Dean Y Li Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,592
+2.11%
|
-
|
|
Jun 27
2024
|
Tina Marriott Larson President and COO |
SELL
Open market or private sale
|
Direct |
6,000
-1.11%
|
$42,000
$7.21 P/Share
|
|
Jun 27
2024
|
Tina Marriott Larson President and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+1.1%
|
$6,000
$1.06 P/Share
|
|
Jun 25
2024
|
Blake Borgeson Director |
SELL
Open market or private sale
|
Direct |
11,447
-0.16%
|
$103,023
$9.51 P/Share
|
|
Jun 14
2024
|
Michael Secora Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
15,000
-1.17%
|
$135,000
$9.27 P/Share
|
|
Jun 14
2024
|
Michael Secora Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
39,375
+2.98%
|
$78,750
$2.22 P/Share
|
|
Jun 13
2024
|
Michael Secora Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
15,000
-1.19%
|
$135,000
$9.32 P/Share
|
|
Jun 13
2024
|
Michael Secora Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
39,375
+3.03%
|
$78,750
$2.22 P/Share
|
|
Jun 11
2024
|
Blake Borgeson Director |
SELL
Open market or private sale
|
Direct |
11,447
-0.16%
|
$91,576
$8.45 P/Share
|
|
Jun 06
2024
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,000
-6.59%
|
$450,000
$9.0 P/Share
|
|
Jun 05
2024
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,000
-6.18%
|
$400,000
$8.42 P/Share
|
|
Jun 05
2024
|
Christopher Gibson Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
25,000
-3.0%
|
-
|
|
Jun 05
2024
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
25,000
+2.91%
|
-
|
|
Jun 03
2024
|
Dean Y Li Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,097
+15.36%
|
-
|
|
Jun 03
2024
|
Zavain Dar Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,097
+11.36%
|
-
|
|
Jun 03
2024
|
Blake Borgeson Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,097
+0.18%
|
-
|
|
Jun 03
2024
|
Robert Hershberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,097
+20.21%
|
-
|
|
Jun 03
2024
|
Terry Ann Burrell Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,097
+15.87%
|
-
|
|
May 30
2024
|
Tina Marriott Larson President and COO |
SELL
Open market or private sale
|
Direct |
3,000
-0.56%
|
$24,000
$8.78 P/Share
|
|
May 30
2024
|
Tina Marriott Larson President and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+0.55%
|
$3,000
$1.06 P/Share
|
|
May 28
2024
|
Blake Borgeson Director |
SELL
Open market or private sale
|
Direct |
11,447
-0.16%
|
$103,023
$9.17 P/Share
|
|
May 15
2024
|
Michael Secora Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,962
-0.97%
|
$119,620
$10.01 P/Share
|
|
May 15
2024
|
Christopher Gibson Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
26,082
-3.12%
|
$260,820
$10.01 P/Share
|
|
May 15
2024
|
David J Mauro Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
867
-0.35%
|
$8,670
$10.01 P/Share
|
|
May 15
2024
|
Tina Marriott Larson President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
9,998
-1.84%
|
$99,980
$10.01 P/Share
|
|
May 14
2024
|
Blake Borgeson Director |
SELL
Open market or private sale
|
Direct |
20,054
-0.28%
|
$200,540
$10.12 P/Share
|
|
May 02
2024
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,000
-2.91%
|
$400,000
$8.47 P/Share
|
|
May 02
2024
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
21,296
+2.43%
|
-
|
|
May 01
2024
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,000
-5.47%
|
$350,000
$7.73 P/Share
|
|
May 01
2024
|
Christopher Gibson Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
25,000
-2.66%
|
-
|
|
Apr 30
2024
|
Blake Borgeson Director |
SELL
Open market or private sale
|
Direct |
11,447
-0.16%
|
$80,129
$7.95 P/Share
|
|
Apr 25
2024
|
Tina Marriott Larson President and COO |
SELL
Open market or private sale
|
Direct |
3,000
-0.55%
|
$21,000
$7.67 P/Share
|
|
Apr 25
2024
|
Tina Marriott Larson President and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+0.55%
|
$3,000
$1.06 P/Share
|
|
Apr 17
2024
|
Michael Secora Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
23,124
-1.84%
|
$161,868
$7.58 P/Share
|
|
Apr 17
2024
|
Michael Secora Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
37,500
+2.9%
|
$75,000
$2.22 P/Share
|
|
Apr 16
2024
|
Michael Secora Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
25,000
-2.01%
|
$175,000
$7.67 P/Share
|
|
Apr 16
2024
|
Michael Secora Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
37,500
+2.93%
|
$75,000
$2.22 P/Share
|
|
Apr 16
2024
|
Blake Borgeson Director |
SELL
Open market or private sale
|
Direct |
11,447
-0.16%
|
$80,129
$7.66 P/Share
|
|
Apr 04
2024
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
25,000
-100.0%
|
$225,000
$9.02 P/Share
|
|
Apr 04
2024
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Indirect |
25,000
+50.0%
|
-
|
|
Apr 04
2024
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
40,000
-4.09%
|
$360,000
$9.02 P/Share
|
|
Apr 03
2024
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
25,000
-100.0%
|
$200,000
$8.84 P/Share
|
|
Apr 03
2024
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Indirect |
25,000
+50.0%
|
-
|